LUKAS SCHEIBLER - 11 Feb 2022 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
CHIEF INNOVATION OFFICER
Signature
/s/ David Watson, attorney-in-fact for Lukas Scheibler
Issuer symbol
APLS
Transactions as of
11 Feb 2022
Net transactions value
-$77,969
Form type
4
Filing time
14 Feb 2022, 17:20:33 UTC
Previous filing
14 Feb 2022
Next filing
15 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Sale $77,969 -1,666 -3.1% $46.80 51,513 11 Feb 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This is a scheduled sale from 10B5-1 trading plan.